ILMN logo

ILMN
Illumina Inc

12,714
Mkt Cap
$15.21B
Volume
554.00
52W High
$156.66
52W Low
$68.70
PE Ratio
12.53
ILMN Fundamentals
Price
$98.96
Prev Close
$99.50
Open
$100.41
50D MA
$98.20
Beta
1.24
Avg. Volume
1.55M
EPS (Annual)
-$7.69
P/B
6.75
Rev/Employee
$421,600.77
Loading...
Loading...
News
all
press releases
Keros Therapeutics (KROS) Moves 9.8% Higher: Will This Strength Last?
Keros Therapeutics (KROS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·22h ago
News Placeholder
More News
News Placeholder
PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations
PACB unveils new SPRQ-Nx chemistry to cut sequencing costs and boost multiomic features on Revio and Vega.
Zacks·2d ago
News Placeholder
KMDA or ILMN: Which Is the Better Value Stock Right Now?
KMDA vs. ILMN: Which Stock Is the Better Value Option?
Zacks·7d ago
News Placeholder
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot...
PR Newswire·7d ago
News Placeholder
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights Illumina fuels multiomic discovery with launch of 5-base solution, unlocking...
PR Newswire·7d ago
News Placeholder
Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025
Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025 Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025 PR Newswire SAN DIEGO...
PR Newswire·8d ago
News Placeholder
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Zacks·12d ago
News Placeholder
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·13d ago
News Placeholder
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report?
Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks·15d ago
News Placeholder
ILMN Stock Set to Benefit From the Launch of New BioInsight Division
Illumina launches BioInsight to harness multiomic data, accelerate drug discovery, and boost disease diagnosis.
Zacks·19d ago

Latest ILMN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.